In Study of Mantle Cell Lymphoma and Acute Myeloid Leukemia Samples, ONC201 Shows Promising Results
News
In a new study, researchers at the University of Texas MD Anderson Cancer Center found that ONC201, a first-in-class anticancer drug being developed in partnership with Oncoceutics Inc., caused cancer ... Read more